AWH Aspira Women's Health Inc

Price (delayed)

$4.88

Market cap

$546.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$491.84M

Highlights
Aspira Women's Health's revenue has increased by 6% from the previous quarter
The debt has declined by 4.9% since the previous quarter
AWH's gross profit is up by 15% since the previous quarter but it is down by 6% year-on-year
The company's gross margin rose by 8% QoQ but it fell by 5% YoY
The net income has declined by 32% year-on-year and by 12% since the previous quarter
The EPS has contracted by 6% from the previous quarter and by 6% YoY

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
111.95M
Market cap
$546.3M
Enterprise value
$491.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.42
Price to sales (P/S)
107.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
99.83
Earnings
Revenue
$4.93M
EBIT
-$20.1M
EBITDA
-$19.76M
Free cash flow
-$17M
Per share
EPS
-$0.19
Free cash flow per share
-$0.16
Book value per share
$0.47
Revenue per share
$0.05
TBVPS
$0.57
Balance sheet
Total assets
$62.3M
Total liabilities
$9.97M
Debt
$4.91M
Equity
$52.33M
Working capital
$55.23M
Liquidity
Debt to equity
0.09
Current ratio
9.98
Quick ratio
9.81
Net debt/EBITDA
2.76
Margins
EBITDA margin
-401%
Gross margin
28.8%
Net margin
-408.3%
Operating margin
-407.3%
Efficiency
Return on assets
-69.2%
Return on equity
-96%
Return on invested capital
-1,830.7%
Return on capital employed
-35.8%
Return on sales
-407.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
-0.61%
1 week
2.95%
1 month
-14.39%
1 year
12.18%
YTD
-27.27%
QTD
-13.17%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$4.93M
Gross profit
$1.42M
Operating income
-$20.07M
Net income
-$20.12M
Gross margin
28.8%
Net margin
-408.3%
The net margin has declined by 33% year-on-year and by 6% since the previous quarter
The net income has declined by 32% year-on-year and by 12% since the previous quarter
Aspira Women's Health's operating margin has decreased by 31% YoY and by 5% from the previous quarter
The operating income has declined by 31% year-on-year and by 12% since the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
10.42
P/S
107.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
99.83
The EPS has contracted by 6% from the previous quarter and by 6% YoY
The stock's P/B is 74% below its last 4 quarters average of 39.9 and 52% below its 5-year quarterly average of 21.7
AWH's price to sales (P/S) is 157% more than its 5-year quarterly average of 42.1 but 3.2% less than its last 4 quarters average of 111.9
Aspira Women's Health's revenue has increased by 6% from the previous quarter

Efficiency

How efficient is Aspira Women's Health business performance
The ROE has soared by 51% from the previous quarter and by 38% YoY
Aspira Women's Health's ROIC has increased by 44% from the previous quarter
The ROA has grown by 38% from the previous quarter and by 33% YoY
The ROS has contracted by 33% YoY and by 6% from the previous quarter

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total liabilities has soared by 97% YoY
The debt is 91% smaller than the equity
Aspira Women's Health's debt to equity has plunged by 83% from the previous quarter and by 61% YoY
The debt has declined by 4.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.